MTOR EXPRESSION ANALYSIS IN LUNG AND GASTROENTEROPANCREATIC POORLY DIFFERENTIATED ENDOCRINE CARCINOMA (PDEC)

被引：0
|
作者：
Catena, L.
Bajetta, E.
Milione, M. [1 ]
Valente, M.
Pusceddu, S.
Ducceschi, M.
Avarino, C. [1 ]
Pietrantonio, F.
Biondani, P.
Colonna, V.
机构：
[1] Fdn IRCCS, Ist Nazl Tumori, Pathol Unit, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：265 / 265
页数：1
相关论文
共 50 条
  • [1] Mammalian Target of Rapamycin (mTOR) Expression Analysis and Therapeutic Approach in Lung and Gastroenteropancreatic Poorly Differentiated Endocrine Carcinoma (PDEC)
    Catena, L.
    Milione, M.
    Pusceddu, S.
    Ducceschi, M.
    Avarino, M.
    Valente, M.
    Colonna, V
    Barone, G.
    Bajetta, E.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 4 - 4
  • [2] mTOR expression in gastrointestinal (GI) tract poorly differentiated endocrine carcinoma (PDEC)
    Catena, L.
    Carbone, A.
    Milione, M.
    Platania, M.
    Ducceschi, M.
    Dominioni, F.
    Di Guardo, L.
    Buzzoni, R.
    Formisano, B.
    Bajetta, E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 145 - 146
  • [3] GASTROINTESTINAL (GI) TRACT POORLY DIFFERENTIATED ENDOCRINE CARCINOMA (PDEC): MAMMALIAN TARGET OF RAPAMYCIN (MTOR) EXPRESSION ANALYSIS
    Catena, Laura
    Milione, Massimo
    Carbone, Antonino
    Platania, Marco
    Ducceschi, Monika
    ANNALS OF ONCOLOGY, 2009, 20
  • [4] Ewing Sarcoma a Dangerous Pitfall for Poorly Differentiated Neuroendocrine Carcinoma (PDEC) in Ileum
    Milione, M.
    Gasparini, P.
    Coppa, J.
    Pusceddu, S.
    Pellegrinelli, A.
    Collini, P.
    Concas, L.
    Buzzoni, R.
    De Braud, F.
    Pilotti, S.
    Mazzaferro, V
    Pelosi, G.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 248 - 248
  • [5] Potential Therapeutic Targets for Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinoma
    Weiss, Vivian L.
    Gonzalez, Raul S.
    Shi, Chanjuan
    LABORATORY INVESTIGATION, 2016, 96 : 206A - 207A
  • [6] Potential Therapeutic Targets for Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinoma
    Weiss, Vivian L.
    Gonzalez, Raul S.
    Shi, Chanjuan
    MODERN PATHOLOGY, 2016, 29 : 206A - 207A
  • [7] Pleomorph poorly differentiated endocrine carcinoma of the rectum
    Pellegrino Crafa
    Massimo Milione
    Cinzia Azzoni
    Francesco Paolo Pilato
    Silvia Pizzi
    Cesare Bordi
    Virchows Archiv, 2003, 442 : 605 - 610
  • [8] Pleomorph poorly differentiated endocrine carcinoma of the rectum
    Crafa, P
    Milione, M
    Azzoni, C
    Pilato, FP
    Pizzi, S
    Bordi, C
    VIRCHOWS ARCHIV, 2003, 442 (06) : 605 - 610
  • [9] Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract
    Furlan, D
    Cerutti, R
    Uccella, S
    La Rosa, S
    Rigoli, E
    Genasetti, A
    Capella, C
    CLINICAL CANCER RESEARCH, 2004, 10 (03) : 947 - 957
  • [10] Clinical Effect of Temozolomide-Based Chemotherapy in Poorly Differentiated Endocrine Carcinoma (PDEC) after Progression on First-Line Chemotherapy
    Welin, S.
    Sorby, H.
    Sebjornsen, S.
    Knappskog, S.
    Busch, C.
    Oberg, K.
    NEUROENDOCRINOLOGY, 2011, 94 : 49 - 49
12345